FTSE 100 steams higher after US equities open mixed proactiveinvestors.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.co.uk Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
NEW YORK, March 1, 2021 /PRNewswire/ AIkido Pharma Inc. (Nasdaq: AIKI) ( AIkido or the Company ) today announced it will be featured as a presenting company at the H.C. Wainwright Global Life Sciences Conference, a virtual conference held March 9-10, 2021. The Company will showcase an updated Investor Presentation and discuss some of its new technology. Darrell Dotson, Vice President and General Counsel, of AIkido Pharma Inc. will present for the Company.
If you are an institutional investor, and would like to attend the Company s presentation, please click on the following link (https://hcwevents.com/globalconference/) to register for the conference.
Apexigen to Present at Investor Conferences in March and April 2021 prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
IDEAYA to Participate in Upcoming March 2021 Investor Relations Events
News provided by
Share this article
Share this article
SOUTH SAN FRANCISCO, Calif., March 1, 2021 /PRNewswire/ IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a synthetic lethality-focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation at the following upcoming investor relations events.
Investor Relations Events
Corporate Presentation
Citi s 2021 Winter West Coast Biotech Virtual Bus Tour (Virtual)
Fireside Chat with Analyst Mohit Bansal
Tuesday, March 16
Oppenheimer s 31
Company Presentation
Roth 33
Oncology Platforms with Arvinas, IDEAYA Biosciences and Turning Point Therapeutics
Wednesday, March 17
th, 2021 at 5:00 pm ET
A live audio webcast of selected events will be available by visiting the Investors/News and Events/Investor Calendar section of the IDEAYA website at https://ir.ideayabio.com/news-events/inves
Celyad Oncology Announces March 2021 Conference Schedule
Regulatory News:
Celyad Oncology SA (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD) (Euronext Nasdaq: CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer, today announced that the company plans to participate at the following virtual investor conferences in March 2021:
H.C. Wainwright Global Life Sciences Conference
Date: Tuesday, March 9 Wednesday, March 10, 2021
Time: 7:00 a.m. ET 1:00 p.m. CET
Webcast: A webcast of the presentation will be available in the Events section of the Celyad Oncology website for approximately 90 days from the start of the event